Maysa Serpa Gonçalves, Marina Martins de Oliveira, Rafaella Silva Andrade, Luciana Faria de Oliveira, Alessandro de Sá Guimarães, Jacques Godfroid, Andrey Pereira Lage, Elaine Maria Seles Dorneles
{"title":"Systematic review on the effectiveness of Brucella abortus S19 and RB51 vaccine strains in field studies.","authors":"Maysa Serpa Gonçalves, Marina Martins de Oliveira, Rafaella Silva Andrade, Luciana Faria de Oliveira, Alessandro de Sá Guimarães, Jacques Godfroid, Andrey Pereira Lage, Elaine Maria Seles Dorneles","doi":"10.1016/j.vaccine.2024.126649","DOIUrl":null,"url":null,"abstract":"<p><p>Brucella abortus S19 and RB51 are the most used vaccines to control bovine brucellosis worldwide; therefore, this study aimed to perform a systematic review on the effectiveness of these two vaccine strains in field studies. The literature review was conducted on April 3rd 2020 on six databases (CABI, Cochrane, PubMed, Scielo, Scopus and Web of Science) and included papers published between 1976 and 2016. The search strategy recovered a total of 5846 papers on databases and 6 papers were included due to specialists' suggestions. After selection, 17 papers were included, in which 33 trials were identified. Most trials [63.63 % (21/33)] used prevalence panel design (cross-sectional), while the others were cohort studies. S19 strain was used in most of the trials [75.76 % (25/33)], mainly by subcutaneous route [84.00 % (21/25)] and in adult cattle [76.00 % (19/25)]. RB51 strain was administrated only by the subcutaneous route and in both young and adult animals. For case definition, complement fixation [60.60 % (20/33)] and rivanol [30.30 % (10/33)] were the most used tests. Twenty of the 33 trials (60.61 %) showed significant effect of vaccination on brucellosis control, with lower incidence of infection in the vaccinated groups (in cohort trials) or reduced prevalence after vaccination (in prevalence panels); however, the great heterogeneity observed among the studies precluded a meta-analysis from the data extracted. In addition, most trials [57.57 % (19/33)] adopted other control measures (test-and-slaughter or isolation of positive animals from the herd) in association with vaccination, which harmed the better understand of the isolated effect of vaccination for brucellosis control in field in these studies. In conclusion, the result from this review suggests that both S19 and RB51 vaccine strains are effective in reducing brucellosis incidence in both calves and adults, as well as abortion rates, mainly when associated to other control policies.</p>","PeriodicalId":94264,"journal":{"name":"Vaccine","volume":"45 ","pages":"126649"},"PeriodicalIF":0.0000,"publicationDate":"2025-01-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vaccine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.vaccine.2024.126649","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/12/21 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Brucella abortus S19 and RB51 are the most used vaccines to control bovine brucellosis worldwide; therefore, this study aimed to perform a systematic review on the effectiveness of these two vaccine strains in field studies. The literature review was conducted on April 3rd 2020 on six databases (CABI, Cochrane, PubMed, Scielo, Scopus and Web of Science) and included papers published between 1976 and 2016. The search strategy recovered a total of 5846 papers on databases and 6 papers were included due to specialists' suggestions. After selection, 17 papers were included, in which 33 trials were identified. Most trials [63.63 % (21/33)] used prevalence panel design (cross-sectional), while the others were cohort studies. S19 strain was used in most of the trials [75.76 % (25/33)], mainly by subcutaneous route [84.00 % (21/25)] and in adult cattle [76.00 % (19/25)]. RB51 strain was administrated only by the subcutaneous route and in both young and adult animals. For case definition, complement fixation [60.60 % (20/33)] and rivanol [30.30 % (10/33)] were the most used tests. Twenty of the 33 trials (60.61 %) showed significant effect of vaccination on brucellosis control, with lower incidence of infection in the vaccinated groups (in cohort trials) or reduced prevalence after vaccination (in prevalence panels); however, the great heterogeneity observed among the studies precluded a meta-analysis from the data extracted. In addition, most trials [57.57 % (19/33)] adopted other control measures (test-and-slaughter or isolation of positive animals from the herd) in association with vaccination, which harmed the better understand of the isolated effect of vaccination for brucellosis control in field in these studies. In conclusion, the result from this review suggests that both S19 and RB51 vaccine strains are effective in reducing brucellosis incidence in both calves and adults, as well as abortion rates, mainly when associated to other control policies.
流产布鲁氏菌S19和RB51是世界范围内控制牛布鲁氏菌病最常用的疫苗;因此,本研究旨在对这两种疫苗株在实地研究中的有效性进行系统评价。文献综述于2020年4月3日在六个数据库(CABI、Cochrane、PubMed、Scielo、Scopus和Web of Science)上进行,包括1976年至2016年间发表的论文。检索策略在数据库中共检索到5846篇论文,根据专家建议,有6篇论文被纳入。经筛选,纳入文献17篇,共鉴定试验33项。大多数试验[63.63%(21/33)]采用患病率面板设计(横断面),其他试验采用队列研究。S19菌株在大多数试验中使用[75.76%(25/33)],主要通过皮下途径使用[84.00 %(21/25)],在成年牛中使用[76.00 %(19/25)]。RB51菌株仅通过皮下给药,在幼龄和成年动物中均有效。对于病例定义,补体固定[60.60%(20/33)]和利凡诺[30.30%(10/33)]是最常用的检测方法。33项试验中有20项(60.61%)显示疫苗接种对布鲁氏菌病控制有显著影响,接种疫苗组(队列试验)的感染发生率较低,接种疫苗后的患病率降低(流行病学调查);然而,在这些研究中观察到的巨大异质性妨碍了对提取的数据进行荟萃分析。此外,大多数试验[57.57%(19/33)]在接种疫苗的同时采取了其他控制措施(试验屠宰或从畜群中隔离阳性动物),这不利于更好地了解这些研究中接种疫苗对布鲁氏菌病现场控制的孤立效果。总之,本综述的结果表明,S19和RB51疫苗株都能有效降低犊牛和成牛的布鲁氏菌病发病率,以及流产率,主要是在与其他控制政策相结合的情况下。